📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

MORC3 represses the HCMV major immediate early promoter in myeloid cells in the absence of PML nuclear bodies (2023)

First Author: Champion A

Attributed to: Human cytomegalovirus: changes in the latently infected cell as chemotherapeutic and immunological targets for antiviral therapy funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/jmv.29227

PubMed Identifier: 38009611

Publication URI: http://europepmc.org/abstract/MED/38009611

Type: Journal Article/Review

Parent Publication: Journal of Medical Virology

Issue: 11

ISSN: 0146-6615